CDKN2A and cancer: Critical evidence for the role of senescent cells in age-related disease comes from research demonstrating that removal of p16INK4a-positive cells can prevent or slow the deterioration of several tissues and organs, delay tumor growth, and reduce metastasis in mice exposed to cytotoxic cancer treatments [15, 16].